NHGRI is offering a grant for small businesses to develop novel technologies for significant improvements in DNA sequencing and practical methods for direct RNA sequencing. The goal is to enhance DNA sequencing quality, efficiency, and enable direct RNA sequencing with advancements like longer read lengths, faster turnaround time, and greater accuracy at reasonable costs. The anticipated contributions to NHGRI’s genomics mission and other technology development goals make this grant valuable for driving innovation in genomics research. Closing date for applications is Sep 10, 2020.
Opportunity ID: 303757
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-HG-18-003 |
Funding Opportunity Title: | Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.172 — Human Genome Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 18, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Sep 10, 2020 |
Current Closing Date for Applications: | Sep 10, 2020 |
Archive Date: | Oct 16, 2020 |
Estimated Total Program Funding: | $1,500,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) solicits R43/R44 grant applications from small businesses to develop novel technologies that will enable no less than one order of magnitude improvement in DNA sequencing, and practical methods for direct RNA sequencing. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained DNA sequencing throughput increases and cost decreases. The goal now is to improve the quality and efficiency of DNA sequencing and enable direct RNA sequencing (e.g., longer read lengths, faster turn-around time, greater accuracy, and higher-throughput etc.) at reasonable costs with the anticipation that significant advances in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRIs other technology development goals. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-003.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00241019 | May 27, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260333 | May 27, 2018 | Sep 10, 2020 | View |
Package 1
Mandatory forms
303757 RR_SF424_2_0-2.0.pdf
303757 PHS398_CoverPageSupplement_4_0-4.0.pdf
303757 RR_OtherProjectInfo_1_4-1.4.pdf
303757 PerformanceSite_2_0-2.0.pdf
303757 RR_KeyPersonExpanded_2_0-2.0.pdf
303757 RR_Budget_1_4-1.4.pdf
303757 PHS398_ResearchPlan_4_0-4.0.pdf
303757 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
303757 RR_SubawardBudget30_1_4-1.4.pdf
303757 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
303757 RR_SF424_2_0-2.0.pdf
303757 PHS398_CoverPageSupplement_5_0-5.0.pdf
303757 RR_OtherProjectInfo_1_4-1.4.pdf
303757 PerformanceSite_2_0-2.0.pdf
303757 RR_KeyPersonExpanded_2_0-2.0.pdf
303757 RR_Budget_1_4-1.4.pdf
303757 PHS398_ResearchPlan_4_0-4.0.pdf
303757 SBIR_STTR_Information_1_3-1.3.pdf
303757 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
303757 RR_SubawardBudget30_1_4-1.4.pdf
303757 PHS_AssignmentRequestForm_3_0-3.0.pdf